OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)
Maryam Maryam, Treesa P. Varghese, Bachi Tazneem
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102411-102411
Closed Access | Times Cited: 16

Showing 16 citing articles:

Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca
Vascular Pharmacology (2025), pp. 107462-107462
Closed Access | Times Cited: 1

Stellate Ganglionectomy Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
Hui Yan, X.Y. Li, Beilei Liu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 2
Open Access

From injury to repair: the therapeutic potential of induced pluripotent stem cells in heart failure
Tadahisa Sugiura, Sheeza Nawaz, Dhienda C. Shahannaz, et al.
Regenerative medicine reports . (2025) Vol. 2, Iss. 1, pp. 22-30
Closed Access

High ADMA Is Associated with Worse Health Profile in Heart Failure Patients Hospitalized for Episodes of Acute Decompensation
Anamaria Vîlcea, Simona Maria Borta, Romana Olivia Popețiu, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 813-813
Open Access | Times Cited: 3

Genetic Markers of Cardiovascular Disease
Treesa P. Varghese
Current Problems in Cardiology (2024) Vol. 49, Iss. 7, pp. 102588-102588
Closed Access | Times Cited: 2

Role of Mitochondria in Reno-Cardiac Diseases: A Study of Bioenergetics, Biogenesis, and GSH Signaling in Disease Transition
Jairo Lumpuy‐Castillo, Isabel Amador‐Martínez, Miriam Díaz-Rojas, et al.
Redox Biology (2024) Vol. 76, pp. 103340-103340
Open Access | Times Cited: 2

Innovative hypertension treatments: transitioning from conventional therapies to siRNA-based solutions
Reza Parvan, Joseph Pierre Aboumsallem, Wouter C. Meijers, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177110-177110
Open Access | Times Cited: 2

Sex Differences in Cardiovascular Diseases: Exploring the Role of Microbiota and Immunity
Laura Franza, Mario Caldarelli, Emanuele Rocco Villani, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1645-1645
Open Access | Times Cited: 1

Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
Tianyu Wang, Qiang Yang, Xinyi Cheng, et al.
Heart Failure Reviews (2024)
Closed Access | Times Cited: 1

Pathogenesis of cardiovascular diseases: effects of mitochondrial CF6 on endothelial cell function
Yingying Zhao, Ming Yang, Youren Liu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access

The immune regulatory role of exosomal miRNAs and their clinical application potential in heart failure
Dandan Guo, Jianjun Yan, Zhenyu Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

SIRT1-FOXOs signaling pathway: A potential target for attenuating cardiomyopathy
Changxu Lu, Can Gao, Jinwen Wei, et al.
Cellular Signalling (2024), pp. 111409-111409
Closed Access

Page 1

Scroll to top